Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary...

Area of Science:

• Cardiology
• Cardiovascular Research
• Interventional Cardiology

Background:

• Acute myocardial infarction (AMI) requires prompt reperfusion therapy.
• Microvascular dysfunction can limit the effectiveness of primary percutaneous coronary intervention (PCI).
• Adenosine's role in improving microvascular function post-PCI needs further evaluation.

Purpose of the Study:

• To assess the impact of intravenous adenosine on microvascular reflow.
• To evaluate its effect on infarct size in AMI patients undergoing primary stenting.
• To determine if timing of intervention influences adenosine's efficacy.

Main Methods:

• Thirty AMI patients undergoing primary stenting were randomized to adenosine or placebo.
• Myocardial contrast echocardiography (MCE) assessed risk area and infarct size before and after stenting.
• MCE was repeated sequentially to evaluate microvascular blood volume.

Main Results:

• Adenosine treatment significantly reduced infarct size relative to risk area at 3-5 days and 4 weeks post-PCI (p <0.01).
• This benefit was most pronounced when reperfusion occurred within 4 hours of symptom onset (p <0.05).
• Higher relative microvascular blood volume was observed in the adenosine group at 4 weeks (p <0.01).

Conclusions:

• Adjunctive intravenous adenosine therapy effectively reduces infarct size after primary stenting in AMI.
• The beneficial effects of adenosine are most significant when reperfusion is achieved early (<4 hours).
• Adenosine improves microvascular reflow, contributing to reduced myocardial damage in AMI patients.